Christopher Cody Tipton, MD - Medicare Orthopedic Surgery in Vicksburg, MS

Christopher Cody Tipton, MD is a medicare enrolled "Orthopaedic Surgery" physician in Vicksburg, Mississippi. He went to Howard University College Of Medicine and graduated in 2015 and has 9 years of diverse experience with area of expertise as Orthopedic Surgery. He is a member of the group practice Vicksburg Clinic Llc and his current practice location is 2100 Highway 61 N, Vicksburg, Mississippi. You can reach out to his office (for appointments etc.) via phone at (601) 883-3553.

Christopher Cody Tipton is licensed to practice in Mississippi (license number 28824) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1801282223.

Contact Information

Christopher Cody Tipton, MD
2100 Highway 61 N,
Vicksburg, MS 39183-8211
(601) 883-3553
Not Available



Physician's Profile

Full NameChristopher Cody Tipton
GenderMale
SpecialityOrthopedic Surgery
Experience9 Years
Location2100 Highway 61 N, Vicksburg, Mississippi
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Christopher Cody Tipton attended and graduated from Howard University College Of Medicine in 2015
  NPI Data:
  • NPI Number: 1801282223
  • Provider Enumeration Date: 04/13/2015
  • Last Update Date: 12/14/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 2466763156
  • Enrollment ID: I20210628000074

Medical Identifiers

Medical identifiers for Christopher Cody Tipton such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1801282223NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207X00000XOrthopaedic Surgery 28824 (Mississippi)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Mid Delta Home Health AgencyBelzoni, MSHome health agency
Encompass Health-home HealthVicksburg, MSHome health agency
Kindred At Home -flowoodFlowood, MSHome health agency
Merit Health River RegionVicksburg, MSHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Vicksburg Clinic Llc589069633021

News Archive

Scientists look for new ways to fight TB

Scientists looking for new ways to fight tuberculosis have their sights set on a structure essential to the bacterium's survival. Disabling this structure could kill the microbes in the infected host and thwart TB infections. In a study appearing online May 11, 2010, in EMBO J, the journal of the European Molecular Biology Organization, scientists from the U.S. Department of Energy's Brookhaven National Laboratory, Stony Brook University, and Weill Cornell Medical College describe new features of how this structure, known as a proteasome, is put together and how it works.

New evidence that SARS-CoV-2 virus can infect the inner ear

Many Covid-19 patients have reported symptoms affecting the ears, including hearing loss and tinnitus. Dizziness and balance problems can also occur, suggesting that the SARS-CoV-2 virus may be able to infect the inner ear.

Way now clear for FDA approval of Plan B "morning-after" pill

Now that senators Patty Murray of Washington and Hillary Clinton of New York, have dropped their objections to acting FDA Commissioner Lester Crawford becoming the permanent commissioner, approval for the sale of the Plan B "morning-after" contraceptive without a prescription should be granted with the minimum of delay.

Amgen announces PRIME '203' and '181' Phase 3 trial results

Amgen today announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating Vectibix (panitumumab) in combination with chemotherapy (FOLFOX or FOLFIRI) as a first and second-line treatment for metastatic colorectal cancer (mCRC), respectively, were published online in the Journal of Clinical Oncology.

Bipolar disorder drug market to decline from $6.3 billion to $5 billion

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that widespread generic erosion of branded atypical antipsychotics will cause the bipolar disorder drug market to decline from $6.3 billion in 2008 to approximately $5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Christopher Cody Tipton allows following entities to bill medicare on his behalf.
Entity NameVicksburg Clinic Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1790711158
PECOS PAC ID: 5890696330
Enrollment ID: O20040116000738

News Archive

Scientists look for new ways to fight TB

Scientists looking for new ways to fight tuberculosis have their sights set on a structure essential to the bacterium's survival. Disabling this structure could kill the microbes in the infected host and thwart TB infections. In a study appearing online May 11, 2010, in EMBO J, the journal of the European Molecular Biology Organization, scientists from the U.S. Department of Energy's Brookhaven National Laboratory, Stony Brook University, and Weill Cornell Medical College describe new features of how this structure, known as a proteasome, is put together and how it works.

New evidence that SARS-CoV-2 virus can infect the inner ear

Many Covid-19 patients have reported symptoms affecting the ears, including hearing loss and tinnitus. Dizziness and balance problems can also occur, suggesting that the SARS-CoV-2 virus may be able to infect the inner ear.

Way now clear for FDA approval of Plan B "morning-after" pill

Now that senators Patty Murray of Washington and Hillary Clinton of New York, have dropped their objections to acting FDA Commissioner Lester Crawford becoming the permanent commissioner, approval for the sale of the Plan B "morning-after" contraceptive without a prescription should be granted with the minimum of delay.

Amgen announces PRIME '203' and '181' Phase 3 trial results

Amgen today announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating Vectibix (panitumumab) in combination with chemotherapy (FOLFOX or FOLFIRI) as a first and second-line treatment for metastatic colorectal cancer (mCRC), respectively, were published online in the Journal of Clinical Oncology.

Bipolar disorder drug market to decline from $6.3 billion to $5 billion

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that widespread generic erosion of branded atypical antipsychotics will cause the bipolar disorder drug market to decline from $6.3 billion in 2008 to approximately $5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Christopher Cody Tipton is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Christopher Cody Tipton, MD
2100 Highway 61 N,
Vicksburg, MS 39183-8211

Ph: (601) 883-3553
Christopher Cody Tipton, MD
2100 Highway 61 N,
Vicksburg, MS 39183-8211

Ph: (601) 883-3553

News Archive

Scientists look for new ways to fight TB

Scientists looking for new ways to fight tuberculosis have their sights set on a structure essential to the bacterium's survival. Disabling this structure could kill the microbes in the infected host and thwart TB infections. In a study appearing online May 11, 2010, in EMBO J, the journal of the European Molecular Biology Organization, scientists from the U.S. Department of Energy's Brookhaven National Laboratory, Stony Brook University, and Weill Cornell Medical College describe new features of how this structure, known as a proteasome, is put together and how it works.

New evidence that SARS-CoV-2 virus can infect the inner ear

Many Covid-19 patients have reported symptoms affecting the ears, including hearing loss and tinnitus. Dizziness and balance problems can also occur, suggesting that the SARS-CoV-2 virus may be able to infect the inner ear.

Way now clear for FDA approval of Plan B "morning-after" pill

Now that senators Patty Murray of Washington and Hillary Clinton of New York, have dropped their objections to acting FDA Commissioner Lester Crawford becoming the permanent commissioner, approval for the sale of the Plan B "morning-after" contraceptive without a prescription should be granted with the minimum of delay.

Amgen announces PRIME '203' and '181' Phase 3 trial results

Amgen today announced that results from the PRIME '203' and '181' pivotal Phase 3 trials evaluating Vectibix (panitumumab) in combination with chemotherapy (FOLFOX or FOLFIRI) as a first and second-line treatment for metastatic colorectal cancer (mCRC), respectively, were published online in the Journal of Clinical Oncology.

Bipolar disorder drug market to decline from $6.3 billion to $5 billion

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that widespread generic erosion of branded atypical antipsychotics will cause the bipolar disorder drug market to decline from $6.3 billion in 2008 to approximately $5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

Read more News

› Verified 9 days ago


Orthopaedic Surgery Doctors in Vicksburg, MS

Daniel P Dare, MD
Orthopedic Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 2080 S Frontage Rd, Suite 113, Vicksburg, MS 39180
Phone: 601-636-1219    Fax: 601-636-1076
Tulio Figarola,
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 2100 Highway 61 N, Vicksburg, MS 39183
Phone: 601-883-3391    Fax: 901-883-3395
Erica Kellyn Smith, PA-C, ATC
Orthopedic Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 2100 Highway 61 N, Vicksburg, MS 39183
Phone: 601-883-5000    
William C Porter Jr., MD
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 2100 Highway 61 N, Vicksburg, MS 39183
Phone: 601-883-5000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.